Skip to main content
SpringerLink
Log in

Colorectal Cancer: Screening

  • Chapter
  • First Online:
The ASCRS Textbook of Colon and Rectal Surgery

  • 3325 Accesses

Abstract

Cancer of the colon and rectum is the second leading cause of cancer-related death in the USA. In 2009, it was estimated that 147,000 Americans will be diagnosed with colorectal cancer and 50,000 will die from this disease.1 Without undergoing screening or preventive action, approximately 1 in every 17 people in this country will develop colorectal cancer at some point in life. There is clear evidence that colorectal adenocarcinoma can be prevented by detecting and removing adenomatous polyps and that detecting early stage cancers reduces mortality from the disease.2–9 Both polyps and early stage cancers are usually asymptomatic; cancers that have grown large enough to cause symptoms have a much worse prognosis. This contrast highlights the need for screening in asymptomatic persons.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    PubMed  Google Scholar 

  2. Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5.

    CAS  PubMed  Google Scholar 

  3. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71.

    CAS  PubMed  Google Scholar 

  4. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–8.

    CAS  PubMed  Google Scholar 

  5. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–81.

    CAS  PubMed  Google Scholar 

  6. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995;155:1741–8.

    CAS  PubMed  Google Scholar 

  7. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.

    CAS  PubMed  Google Scholar 

  8. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.

    PubMed  Google Scholar 

  9. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627–37.

    Google Scholar 

  10. Frame PS, Berg AO, Woolf S. U.S. Preventive Services Task Force: highlights of the 1996 report. Am Fam Physician. 1997;55:567–76. 581–2.

    CAS  PubMed  Google Scholar 

  11. Levin B, Bond JH. Colorectal cancer screening: recommendations of the U.S. Preventive Services Task Force. American Gastroenterological Association. Gastroenterology. 1996;111:1381–4.

    CAS  PubMed  Google Scholar 

  12. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 1997;17:79–83.

    CAS  PubMed  Google Scholar 

  13. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642.

    CAS  PubMed  Google Scholar 

  14. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin. 1997;47:154–60.

    CAS  PubMed  Google Scholar 

  15. Simmang CL, Senatore P, Lowry A, et al. Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1999;42:1123–9.

    CAS  PubMed  Google Scholar 

  16. Ko C, Hyman NH. Practice parameter for the detection of colorectal neoplasms: an interim report (revised). Dis Colon Rectum. 2006;49:299–301.

    PubMed  Google Scholar 

  17. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–60.

    PubMed  Google Scholar 

  18. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739–50.

    PubMed  Google Scholar 

  19. Inadomi J, Kuhn L, Vijan S, et al. Adherence to competing colorectal cancer screening strategies. Am J Gastroenterol. 2005;100:S387–8.

    Google Scholar 

  20. Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med. 1998;339:153–9.

    CAS  PubMed  Google Scholar 

  21. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.

    CAS  PubMed  Google Scholar 

  22. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.

    CAS  PubMed  Google Scholar 

  23. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007. CD001216.

    Google Scholar 

  24. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85:840–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997;126:811–22.

    CAS  PubMed  Google Scholar 

  27. Nakama H, Fattah AS, Zhang B, Kamijo N. Digital rectal examination sampling of stool is less predictive of significant colorectal pathology than stool passed spontaneously. Eur J Gastroenterol Hepatol. 2000;12:1235–8.

    CAS  PubMed  Google Scholar 

  28. Colorectal Cancer Screening. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2003;1:72–93.

    Google Scholar 

  29. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med. 2002;346:311–20.

    CAS  PubMed  Google Scholar 

  30. Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am J Gastroenterol. 2003;98:2299–305.

    CAS  PubMed  Google Scholar 

  31. An SW, Kim NK, Chung HC. Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening. Yonsei Med J. 2009;50:331–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704–14.

    CAS  PubMed  Google Scholar 

  33. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008;149:441–50. W481.

    PubMed  PubMed Central  Google Scholar 

  34. Read TE, Read JD, Butterly LF. Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med. 1997;336:8–12.

    CAS  PubMed  Google Scholar 

  35. Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.

    CAS  PubMed  Google Scholar 

  36. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol. 1999;34:414–20.

    CAS  PubMed  Google Scholar 

  37. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up. Am J Gastroenterol. 2001;96:1901–7.

    CAS  PubMed  Google Scholar 

  38. Pinsky PF, Schoen RE, Weissfeld JL, Kramer B, Hayes RB, Yokochi L. Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol. 2005;3:792–7.

    PubMed  Google Scholar 

  39. Atkin WS, Edwards R, Wardle J, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen. 2001;8:137–44.

    CAS  PubMed  Google Scholar 

  40. Adams C, Cardwell C, Cook C, Edwards R, Atkin WS, Morton DG. Effect of hysterectomy status on polyp detection rates at screening flexible sigmoidoscopy. Gastrointest Endosc. 2003;57:848–53.

    PubMed  Google Scholar 

  41. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338:b1846.

    PubMed  PubMed Central  Google Scholar 

  42. Lieberman D, Smith F. Screening for colon malignancy with colonoscopy. Am J Gastroenterol. 1991;86:946–51.

    CAS  PubMed  Google Scholar 

  43. Achkar E, Carey W. Small polyps found during fiberoptic sigmoidoscopy in asymptomatic patients. Ann Intern Med. 1988;109:880–3.

    CAS  PubMed  Google Scholar 

  44. Brady PG, Straker RJ, McClave SA, Nord HJ, Pinkas M, Robinson BE. Are hyperplastic rectosigmoid polyps associated with an increased risk of proximal colonic neoplasms? Gastrointest Endosc. 1993;39:481–5.

    CAS  PubMed  Google Scholar 

  45. Rex DK, Smith JJ, Ulbright TM, Lehman GA. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology. 1992;102:317–9.

    CAS  PubMed  Google Scholar 

  46. Mehran A, Jaffe P, Efron J, Vernavay A, Liberman A. Screening colonoscopy in the asymptomatic 50- to 59-year-old ­population. Surg Endosc. 2003;17:1974–7.

    CAS  PubMed  Google Scholar 

  47. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–8.

    CAS  PubMed  Google Scholar 

  48. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–74.

    CAS  PubMed  Google Scholar 

  49. Steine S, Stordahl A, Lunde OC, Loken K, Laerum E. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam Pract. 1993;10:288–91.

    CAS  PubMed  Google Scholar 

  50. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst. 1990;82:1769–72.

    CAS  PubMed  Google Scholar 

  51. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc. 1991;37:125–7.

    CAS  PubMed  Google Scholar 

  52. Fork FT. Double contrast enema and colonoscopy in polyp detection. Gut. 1981;22:971–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Fenlon HM, Nunes DP, Clarke PD, Ferrucci JT. Colorectal neoplasm detection using virtual colonoscopy: a feasibility study. Gut. 1998;43:806–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Rex DK. CT and MR colography (virtual colonoscopy): status report. J Clin Gastroenterol. 1998;27:199–203.

    CAS  PubMed  Google Scholar 

  55. Akerkar GA, Yee J, Hung R, McQuaid K. Patient experience and preferences toward colon cancer screening: a comparison of virtual colonoscopy and conventional colonoscopy. Gastrointest Endosc. 2001;54:310–5.

    CAS  PubMed  Google Scholar 

  56. Fenlon HM, Nunes DP, Schroy 3rd PC, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999;341:1496–503.

    CAS  PubMed  Google Scholar 

  57. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359:1207–17.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Gluecker TM, Johnson CD, Harmsen WS, et al. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology. 2003;227:378–84.

    PubMed  Google Scholar 

  59. Lieberman D, Moravec M, Holub J, Michaels L, Eisen G. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135:1100–5.

    PubMed  PubMed Central  Google Scholar 

  60. Rex DK, Imperiale TF. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2008;358:88. author reply 90.

    CAS  PubMed  Google Scholar 

  61. Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA. 2004;291:1713–9.

    CAS  PubMed  Google Scholar 

  62. Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet. 2005;365:305–11.

    CAS  PubMed  Google Scholar 

  63. Butterly LF, Chase MP, Pohl H, Fiarman GS. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol. 2006;4:343–8.

    PubMed  Google Scholar 

  64. Wagner JL. Cost-effectiveness of screening for common cancers. Cancer Metastasis Rev. 1997;16:281–94.

    CAS  PubMed  Google Scholar 

  65. Wagner J, The Congressional Office of Technology Assessment. JAMA. 1990;264:2732.

    CAS  PubMed  Google Scholar 

  66. Sheldon GF. Professionalism, managed care and the human rights movement. Bull Am Coll Surg. 1998;83:13–33.

    CAS  PubMed  Google Scholar 

  67. Brooks DD, Winawer SJ, Rex DK, et al. Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician. 2008;77:995–1002.

    PubMed  Google Scholar 

  68. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med. 1996;334:82–7.

    CAS  PubMed  Google Scholar 

  69. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669–74.

    CAS  PubMed  Google Scholar 

  70. Frayling IM, Beck NE, Ilyas M, et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA. 1998;95:10722–7.

    CAS  PubMed  Google Scholar 

  71. Gryfe R, Di NN, Lal G, Gallinger S, Redston M. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet. 1999;64:378–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Prior TW, Chadwick RB, Papp AC, et al. The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology. 1999;116:58–63.

    CAS  PubMed  Google Scholar 

  73. Rozen P, Shomrat R, Strul H, et al. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology. 1999;116:54–7.

    CAS  PubMed  Google Scholar 

  74. Woodage T, King SM, Wacholder S, et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet. 1998;20:62–5.

    CAS  PubMed  Google Scholar 

  75. Gryfe R, Di NN, Gallinger S, Redston M. Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res. 1998;58:4040–3.

    CAS  PubMed  Google Scholar 

  76. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997;277:915–9.

    CAS  PubMed  Google Scholar 

  77. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996;78:1149–67.

    CAS  PubMed  Google Scholar 

  78. Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bulow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol. 1997;32:572–6.

    CAS  PubMed  Google Scholar 

  79. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758–62.

    CAS  PubMed  Google Scholar 

  80. Box JC, Rodriguez-Bigas MA, Weber TK, Petrelli NJ. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum. 1999;42:717–21.

    CAS  PubMed  Google Scholar 

  81. Fitzgibbons Jr RJ, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg. 1987;206:289–95.

    PubMed  PubMed Central  Google Scholar 

  82. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998;83:259–66.

    CAS  PubMed  Google Scholar 

  83. Park JG, Vasen HF, Park KJ, et al. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum. 1999;42:710–5.

    CAS  PubMed  Google Scholar 

  84. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Samowitz WS, Slattery ML, Kerber RA. Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology. 1995;109:1765–71.

    CAS  PubMed  Google Scholar 

  86. East JE, Suzuki N, Stavrinidis M, Guenther T, Thomas HJ, Saunders BP. Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut. 2008;57:65–70.

    CAS  PubMed  Google Scholar 

  87. Lecomte T, Cellier C, Meatchi T, et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol. 2005;3:897–902.

    PubMed  Google Scholar 

  88. Stoffel EM, Turgeon DK, Stockwell DH, et al. Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila). 2008;1:507–13.

    Google Scholar 

  89. Stoffel EM, Turgeon DK, Stockwell DH, et al. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila). 2008;1:470–5.

    Google Scholar 

  90. Leppert M, Dobbs M, Scambler P, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science. 1987;238:1411–3.

    CAS  PubMed  Google Scholar 

  91. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990;33:639–42.

    CAS  PubMed  Google Scholar 

  92. Vasen HF, Griffioen G, Offerhaus GJ, et al. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum. 1990;33:227–30.

    CAS  PubMed  Google Scholar 

  93. Rustin RB, Jagelman DG, McGannon E, Fazio VW, Lavery IC, Weakley FL. Spontaneous mutation in familial adenomatous polyposis. Dis Colon Rectum. 1990;33:52–5.

    CAS  PubMed  Google Scholar 

  94. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993;75:951–7.

    CAS  PubMed  Google Scholar 

  95. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336:823–7.

    CAS  PubMed  Google Scholar 

  96. Cromwell DM, Moore RD, Brensinger JD, Petersen GM, Bass EB, Giardiello FM. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis. Gastroenterology. 1998;114:893–901.

    CAS  PubMed  Google Scholar 

  97. Winawer SJ. Screening of colorectal cancer. Surg Oncol Clin N Am. 2005;14:699–722.

    PubMed  Google Scholar 

  98. Marcello PW, Asbun HJ, Veidenheimer MC, et al. Gastroduodenal polyps in familial adenomatous polyposis. Surg Endosc. 1996;10:418–21.

    CAS  PubMed  Google Scholar 

  99. Ahmadi AA, Polyak S. Endoscopy/surveillance in inflammatory bowel disease. Surg Clin North Am. 2007;87:743–62.

    PubMed  Google Scholar 

  100. Provenzale D, Kowdley KV, Arora S, Wong JB. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology. 1995;109:1188–96.

    CAS  PubMed  Google Scholar 

  101. Lennard JJ, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990;31:800–6.

    Google Scholar 

  102. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:1623–30.

    PubMed  Google Scholar 

  103. Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev. 2009;18:2170–5.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Colon and Rectal Surgery, Tufts University School of Medicine, Boston, MA, USA

    Jason F. Hall MD

  2. Lahey Clinic, Burlington, MA, USA

    Jason F. Hall MD

  3. Department of Colon and Rectal Surgery, Program Director, Colon and Rectal Surgery Residency, Tufts University School of Medicine, Boston, MA, USA

    Thomas E. Read MD, FACS, FASCRS

  4. Lahey Clinic Medical Center, Burlington, MA, USA

    Thomas E. Read MD, FACS, FASCRS

Authors
  1. Jason F. Hall MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas E. Read MD, FACS, FASCRS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Colon and Rectal Surgery, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA

    David E. Beck MD, FACS, FASCRS

  2. Department of Colorectal Surgery, Lahey Clinic, Tufts University School of Medicine, Burlington, Massachusetts, USA

    Patricia L. Roberts MD, FACS, FASCRS

  3. Section of Colon and Rectal Surgery, Rush Medical Center, Chicago, Illinois, USA

    Theodore J. Saclarides MD, FACS, FASCRS

  4. Department of Surgery, Spectrum Health, Grand Rapids, Michigan, USA

    Anthony J. Senagore MD, FACS, FASCRS

  5. Department of Surgery, UCI Medical Center, Orange, California, USA

    Michael J. Stamos MD, FACS, FASCRS

  6. Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, Florida, USA

    Steven D. Wexner MD, FACS, FASCRS, FRCS, FRCS(Ed)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 ASCRS (American Society of Colon and Rectal Surgeons)

About this chapter

Cite this chapter

Hall, J.F., Read, T.E. (2011). Colorectal Cancer: Screening. In: Beck, D.E., Roberts, P.L., Saclarides, T.J., Senagore, A.J., Stamos, M.J., Wexner, S.D. (eds) The ASCRS Textbook of Colon and Rectal Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1584-9_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1584-9_39

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1581-8

  • Online ISBN: 978-1-4419-1584-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation